Common Bioresearch Monitoring Violations: Updates from FY 2021 to Now | Goodwin

The Bioresearch Monitoring Program (BIMO), run by the U.S. Food and Drug Administration (FDA), oversees the conduct of on-site inspections and data audits of FDA-regulated research in...

Related Keywords

,Bioresearch Monitoring Program ,Drug Administration ,Compliance Program Guidance Manuals ,Fiscal Year ,Warning Letters ,Investigational New Drug ,Warning Letter ,Biologics License Application ,Program Guidance Manuals ,